You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日總結》恆指跌235點 成交降至1,023億 申洲及藥明生物受壓
港股今日反覆向下。恆指高開30點後掉頭向下,曾跌309點一度低見21,922點,全日跌235點或1.06%,收21,996點;國指跌83點或1.1%,收7,525點;恆生科技指數跌64點或1.4%,收4,557點。大市全日成交總額縮減至1,023.95億元,滬、深港通南下交易因內地清明節假期暫停。 科技股方面,騰訊(00700.HK)跌1.7%報374.2元。阿里巴巴(09988.HK)跌1.6%報112.1元,小米(01810.HK)、京東(09618.HK)及網易(09999.HK)各跌1.2%至1.7%,美團(03690.HK)及百度(09888.HK)各跌2.8%及3.2%。 中芯(00981.HK)去年純利升近1.4倍,股價高開後倒跌1.2%。美圖(01357.HK)去年虧損擴大至4,451萬元人民幣,股價挫14.7%失守1元。 此外,易鑫(02858.HK)跌11.8%,中軟(00354.HK)及祖龍娛樂(09990.HK)各跌7.2%及5.4%,心動(02400.HK)、恆騰(00136.HK)及京東健康(06618.HK)各跌4.3%至4.9%,比亞迪電子(00285.HK)、微盟(02013.HK)、ASM太平洋(00522.HK)及同程旅行(00780.HK)各跌3.2%至3.8%。電訊基建股中通服(00552.HK)績後跌勢延續,全日再跌8.7%報3.55元。 內房股方面,萬科(02202.HK)去年純利跌46%,宣布最多25億人民幣回購A股,萬科H股價低開5.1%後,跌幅收窄至1%。潤地(01109.HK)去年純利升逾8%,全日股價跌1.5%。合景泰富(01813.HK)及融創(01918.HK)各跌8.5%及5.2%。 內需股及消費股普遍下跌,蒙牛(02319.HK)去年純利升43%,股價倒跌3.9%。醫藥股普遍受壓,翰森製藥(03692.HK)及信達生物(01801.HK)各跌14%及11.9%。藥明生物(02269.HK)、康希諾(06185.HK)及石藥(01093.HK)各跌4.9%至6%,綠葉製藥(02186.HK)升6%。 內銀股工行(01398.HK)去年純利升10%,農行(01288.HK)去年純利升近12%,郵儲行(01658.HK)去年淨利潤升19%,三股各升0.7%至1.6%。匯控(00005.HK)升0.5%報54.2元,港交所(00388.HK)跌1.3%報371.4元。 申洲(02313.HK)去年純利跌34%,全日股價挫7.3%。中海油(00883.HK)去年純利增1.82倍及因A股發行暫不派末期息,全日股價跌3.4%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account